The TRIUMPH-2 and SYNCHRONIZE-2 studies show both novel agents to be highly effective, but some questions remain.

BARCELONA, Spain—The DEDICATE-DZHK6 trial comparing TAVI with SAVR in low-to-intermediate-risk German patients with aortic ...

Observational studies from Spain, Italy, and the United States help paint a clearer picture of a growing field.

A postapproval study and a subgroup analysis of complex patients show high efficacy rates for the two limus-eluting ...

This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned. Receive the the latest news, research, and presentations from major meetings ...

The expert consensus decision pathway goes beyond the guidelines to provide practice advice around BP management.

What's ahead at this year's TCT in San Diego? Roxana Mehran hears the highlights from Martin Leon and Juan Granada.

The evolving data now show clear biological efficacy with impact on hard clinical outcomes, says Sahil Parikh.

The observational Swedish data need to be further explored but may have identified a new screening target in stroke ...

This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned.

From PAD to pulmonary embolism and stroke, the meeting promises to be packed with cutting-edge vascular therapy news.